C. Cabellos et al., CURRENT USEFULNESS OF PROCAINE PENICILLIN IN THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA, European journal of clinical microbiology & infectious diseases, 17(4), 1998, pp. 265-268
The aim of this study was to determine whether procaine penicillin cou
ld be used in the treatment of suspected pneumococcal pneumonia of mil
d to moderate severity in an area with a high prevalence of penicillin
resistance. Forty-nine patients were treated with 1.2 (.) 10(6) U of
i.m. procaine penicillin every 12 h. By intent-to-treat analysis, 40 o
f 49 patients were cured and no patient died. Streptococcus pneumoniae
could be demonstrated in 17 patients; 5 of 17 isolates were resistant
to penicillin (MICs 0.25-4 mu g/ml). Fifteen of 17 patients were cure
d with procaine penicillin, one presented allergy, and one was a thera
peutic failure. Mean penicillin serum levels were 2.39+/-1.16 mu g/ml
(peak) and 0.61+/- 0.38 mu g/ml (trough). The results suggest that pro
caine penicillin may still be useful in the empirical therapy of suspe
cted pneumococcal pneumonia.